These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9568690)
1. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Jun HS; Kang Y; Yoon HS; Kim KH; Notkins AL; Yoon JW Diabetes; 1998 Apr; 47(4):576-82. PubMed ID: 9568690 [TBL] [Abstract][Full Text] [Related]
2. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein. Jun HS; Yoon SW; Kang Y; Pak CY; Lee MC; Yoon JW J Gen Virol; 1995 Oct; 76 ( Pt 10)():2557-66. PubMed ID: 7595359 [TBL] [Abstract][Full Text] [Related]
3. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. Jun HS; Kang Y; Notkins AL; Yoon JW J Virol; 1997 Dec; 71(12):9782-5. PubMed ID: 9371645 [TBL] [Abstract][Full Text] [Related]
4. Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus. Bae YS; Yoon JW Diabetes; 1993 Mar; 42(3):435-43. PubMed ID: 8381754 [TBL] [Abstract][Full Text] [Related]
6. Analysis of sequence and pathogenic properties of two variants of encephalomyocarditis virus differing in a single amino acid in VP1. Nelsen-Salz B; Zimmermann A; Wickert S; Arnold G; Botta A; Eggers HJ; Kruppenbacher JP Virus Res; 1996 Apr; 41(2):109-22. PubMed ID: 8738170 [TBL] [Abstract][Full Text] [Related]
7. Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Eun HM; Bae YS; Yoon JW Virology; 1988 Apr; 163(2):369-73. PubMed ID: 2833013 [TBL] [Abstract][Full Text] [Related]
8. Alteration of encephalomyocarditis virus pathogenicity due to a mutation at position 100 of VP1. Zhu S; Ge X; Gong X; Guo X; Chen Y; Yang H Sci China Life Sci; 2011 Jun; 54(6):535-43. PubMed ID: 21706414 [TBL] [Abstract][Full Text] [Related]
9. Two amino acids, Phe 16 and Ala 776, on the polyprotein are most likely to be responsible for the diabetogenicity of encephalomyocarditis virus. Bae YS; Eun HM; Pon RT; Giron D; Yoon JW J Gen Virol; 1990 Mar; 71 ( Pt 3)():639-45. PubMed ID: 1690262 [TBL] [Abstract][Full Text] [Related]
10. Viruses cause type 1 diabetes in animals. Yoon JW; Jun HS Ann N Y Acad Sci; 2006 Oct; 1079():138-46. PubMed ID: 17130545 [TBL] [Abstract][Full Text] [Related]
11. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. Kang Y; Yoon JW J Gen Virol; 1993 Jun; 74 ( Pt 6)():1207-13. PubMed ID: 8389806 [TBL] [Abstract][Full Text] [Related]
12. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells. Kaptur PE; Thomas DC; Giron DJ Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377 [TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of two infectious molecular clones of encephalomyocarditis virus. Naviaux RK; Cohen SH; Vanden Brink KM; Jordan GW J Virol; 1990 Feb; 64(2):913-7. PubMed ID: 2153252 [TBL] [Abstract][Full Text] [Related]
14. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Richardson SJ; Leete P; Bone AJ; Foulis AK; Morgan NG Diabetologia; 2013 Jan; 56(1):185-93. PubMed ID: 23064357 [TBL] [Abstract][Full Text] [Related]
15. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783 [TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of encephalomyocarditis viruses isolated from pigs and rodents in Italy. Knowles NJ; Dickinson ND; Wilsden G; Carra E; Brocchi E; De Simone F Virus Res; 1998 Sep; 57(1):53-62. PubMed ID: 9833886 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Richardson SJ; Willcox A; Bone AJ; Foulis AK; Morgan NG Diabetologia; 2009 Jun; 52(6):1143-51. PubMed ID: 19266182 [TBL] [Abstract][Full Text] [Related]
18. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. Bauer PH; Bronson RT; Fung SC; Freund R; Stehle T; Harrison SC; Benjamin TL J Virol; 1995 Dec; 69(12):7925-31. PubMed ID: 7494305 [TBL] [Abstract][Full Text] [Related]
19. Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss mice. Gould CL; Trombley ML; Bigley NJ; McMannama KG; Giron DJ Proc Soc Exp Biol Med; 1984 Apr; 175(4):449-53. PubMed ID: 6324221 [TBL] [Abstract][Full Text] [Related]
20. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]